Current Perspectives on Gill Health
Infectious and non-infectious gill disorders are well known to cause significant and often far-reaching consequences for salmon farming operations. Branchial pathologies can cause not only direct mortalities but also affect growth performance, the response to other health and welfare challenges, and the ability to successfully manage sea lice. As the economic impact of gill disease becomes better understood, research into both the pathobiology and management of gill disease is also gathering pace.
Join our panel of expert speakers who will share current information on field experience, diagnostics and research of gill diseases in Atlantic salmon aquaculture
June 10, 2022
FREE WEBINAR
09:00 – 11:00 UK
10:00 – 12:00 Norway
Program
| Tidspunkt | Foredrag |
|---|---|
| 09:00 (UK) 10:00 (Norway) | Welcome introduction Chris Matthews, Business Unit Director of PHARMAQ Analytiq, UK and Ireland |
| 09:10 (UK) 10:10 (Norway) | Gill challenges in North of Norway - Practical implications for fish health management Mattias Bendiksen Lind, Havet, Norway |
| 09:25 (UK) 10:25 (Norway) | Gill challenges in the South of Norway - Experience from 2021 season Hanna Sæteraas Bjerke, Åkerblå, Norway |
| 09:40 (UK) 10:40 (Norway) | Gill Swabs and Preventive Gill Monitoring Angela Ashby, Head of Clinical Services, PHARMAQ Analytiq, UK |
| 10:05 (UK) 11:05 (Norway) | Gill health in Nowegian farmed Atlantic salmon Liv Østevik, Veterinary pathologist, PHARMAQ Analytiq, Norway |
| 10:25 (UK) 11:25 (Norway) | Results from field monitoring of gill health in freshwater and seawater - is there a correlation? Svein Alexandersen, Senior Manager Commercial Field Vaccines, Therapy and Technical Equipment, PHARMAQ, Norway |
| 10:45 (UK) 11:45 (Norway) | How to move forward and solve the gill challenges Renate Johansen, Global Product Manager, PHARMAQ Analytiq, Norway |
| 11:00 (UK) 12:00 (Norway) | Close |
